<DOC>
	<DOCNO>NCT00774176</DOCNO>
	<brief_summary>The overall purpose PA-SCOPE determine black rural resident Pennsylvania might high risk deadly , debilitate , costly hospitalization chronic obstructive pulmonary disease ( COPD ) — show repeat acute exacerbation high-risk patient reduce one simple intervention . We believe 1 ) COPD patient black live rural area Pennsylvania high risk acute exacerbation require hospitalization 2 ) elevate risk reduce one simple intervention : access 1-800 Temple Call Center patient get immediate customized advice manage COPD exacerbation early stage . We test beliefs PA-SCOPE . The collaborator Temple University Hospital PA-SCOPE project Lancaster General Hospital , Western Pennsylvania Hospital , Philadelphia College Osteopathic Medicine .</brief_summary>
	<brief_title>Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations</brief_title>
	<detailed_description>- Overall objective : To determine African American rural resident Pennsylvania might high risk deadly , debilitate , costly hospitalization COPD—and show repeat acute exacerbation high-risk patient reduce one simple intervention -- access 1-800 Temple Call Center phone number patient get immediate customized advice manage COPD exacerbation early stage . - Phase 1 : To compare contrast influence race geographic location COPD exacerbation relation severity , comorbidities , treatment pattern , infection rate . To identify potential risk factor COPD exacerbation lead hospitalization . - Phase 2 : To reduce hospitalization death due COPD exacerbation improve patient quality life , lung function , everyday activity level</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Phase 1 &amp; Gene Expression : Current hospitalization COPD exacerbation Phase 1 &amp; 2 : COPD &amp; ONE follow criterion : 1 . History hospitalization COPD exacerbation , OR 2 . Currently supplemental oxygen , OR 3 . History evaluation lung transplant LVRS , OR 4 . &gt; /= 6 month postLVRS Phase 1 2 : 1 . Current former smoker , &gt; /= 20 packyr . smoke history 2 . FEV1 &lt; /= 70 % ; FEV1/FVC &lt; /= 70 % 3 . Life expectancy &gt; 6 month &lt; 20 packyr . smoke history Diagnosis pulmonary fibrosis , bronchiectasis , mediastinal mass , presence pulmonary mass Asthma FEV1 &gt; 70 % FEV1/FVC &gt; 70 %</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>COPD Exacerbation</keyword>
	<keyword>Genetic marker COPD</keyword>
	<keyword>Gene expression COPD exacerbation</keyword>
	<keyword>COPD Exacerbation Symptom Reporting</keyword>
	<keyword>COPD Exacerbation Disease Management</keyword>
	<keyword>COPD Treatment</keyword>
	<keyword>Breathing disorder</keyword>
	<keyword>Emphysema</keyword>
	<keyword>COPD Healthy Control comparators genetic association study .</keyword>
</DOC>